Adelante Capital Management LLC cut its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 23.1% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 337,195 shares of the real estate investment trust's stock after selling 101,431 shares during the period. Omega Healthcare Investors comprises approximately 0.9% of Adelante Capital Management LLC's holdings, making the stock its 27th largest position. Adelante Capital Management LLC owned approximately 0.12% of Omega Healthcare Investors worth $12,840,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. NBC Securities Inc. acquired a new stake in shares of Omega Healthcare Investors during the 1st quarter valued at $29,000. CoreCap Advisors LLC raised its holdings in shares of Omega Healthcare Investors by 177.3% during the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after acquiring an additional 1,009 shares in the last quarter. Park Square Financial Group LLC acquired a new stake in Omega Healthcare Investors during the fourth quarter valued at $61,000. UMB Bank n.a. boosted its position in Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its stake in Omega Healthcare Investors by 1,581.3% in the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock valued at $96,000 after purchasing an additional 2,372 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.
Omega Healthcare Investors Stock Performance
OHI traded down $0.00 during trading on Wednesday, hitting $42.83. The stock had a trading volume of 1,845,742 shares, compared to its average volume of 1,847,123. The firm has a market cap of $12.63 billion, a PE ratio of 14.28, a P/E/G ratio of 2.24 and a beta of 0.71. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The company has a 50 day simple moving average of $40.02 and a 200-day simple moving average of $38.15.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same period last year, the business posted $0.71 earnings per share. The firm's revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.3%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 165.43%.
Insider Transactions at Omega Healthcare Investors
In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.50% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on OHI. Truist Financial lifted their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Scotiabank lifted their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Wells Fargo & Company boosted their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Royal Bank Of Canada raised their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $43.38.
Get Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.